Trust Company’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Sell |
7,211
-1,623
| -18% | -$378K | 0.17% | 52 |
|
|
2026
Q1 | $2.16M | Buy |
8,834
+90
| +1% | +$21K | 0.2% | 52 |
|
|
2025
Q4 | $1.81M | Buy |
8,744
+1,159
| +15% | +$229K | 0.17% | 57 |
|
|
2025
Q3 | $1.41M | Sell |
7,585
-1,898
| -20% | -$325K | 0.14% | 52 |
|
|
2025
Q2 | $1.45M | Sell |
9,483
-3,425
| -27% | -$526K | 0.16% | 52 |
|
|
2025
Q1 | $2.14M | Sell |
12,908
-242
| -2% | -$37.9K | 0.25% | 43 |
|
|
2024
Q4 | $1.9M | Buy |
13,150
+3,076
| +31% | +$477K | 0.22% | 46 |
|
|
2024
Q3 | $1.63M | Sell |
10,074
-532
| -5% | -$84.8K | 0.2% | 46 |
|
|
2024
Q2 | $1.55M | Buy |
10,606
+3,358
| +46% | +$499K | 0.2% | 47 |
|
|
2024
Q1 | $1.15M | Buy |
7,248
+22
| +0.3% | +$3.5K | 0.15% | 52 |
|
|
2023
Q4 | $1.13M | Buy |
7,226
+185
| +3% | +$28.4K | 0.15% | 50 |
|
|
2023
Q3 | $1.1M | Sell |
7,041
-89
| -1% | -$14.7K | 0.18% | 45 |
|
|
2023
Q2 | $1.18M | Sell |
7,130
-500
| -7% | -$80.7K | 0.18% | 46 |
|
|
2023
Q1 | $1.18M | Sell |
7,630
-89
| -1% | -$14.4K | 0.18% | 50 |
|
|
2022
Q4 | $1.36M | Buy |
7,719
+4
| +0.1% | +$691 | 0.22% | 42 |
|
|
2022
Q3 | $1.26M | Buy |
7,715
+329
| +4% | +$55.7K | 0.28% | 39 |
|
|
2022
Q2 | $1.31M | Sell |
7,386
-12
| -0.2% | -$2.14K | 0.28% | 41 |
|
|
2022
Q1 | $1.31M | Sell |
7,398
-929
| -11% | -$158K | 0.26% | 50 |
|
|
2021
Q4 | $1.42M | Buy |
8,327
+19
| +0.2% | +$3.11K | 0.33% | 36 |
|
|
2021
Q3 | $1.34M | Buy |
8,308
+21
| +0.3% | +$3.58K | 0.34% | 34 |
|
|
2021
Q2 | $1.36M | Sell |
8,287
-1,602
| -16% | -$265K | 0.96% | 27 |
|
|
2021
Q1 | $1.63M | Sell |
9,889
-534
| -5% | -$86.4K | 1.17% | 22 |
|
|
2020
Q4 | $1.64M | Buy |
10,423
+709
| +7% | +$105K | 1.3% | 19 |
|
|
2020
Q3 | $1.45M | Buy |
9,714
+2,745
| +39% | +$406K | 1.22% | 20 |
|
|
2020
Q2 | $980K | Sell |
6,969
-152
| -2% | -$22.2K | 0.93% | 32 |
|
|
2020
Q1 | $934K | Sell |
7,121
-1,089
| -13% | -$155K | 1.03% | 27 |
|
|
2019
Q4 | $1.2M | Sell |
8,210
-400
| -5% | -$54.3K | 1.05% | 28 |
|
|
2019
Q3 | $1.11M | Sell |
8,610
-58
| -0.7% | -$7.64K | 1.05% | 30 |
|
|
2019
Q2 | $1.21M | Buy |
8,668
+9
| +0.1% | +$1.25K | 1.11% | 27 |
|
|
2019
Q1 | $1.21M | Buy |
8,659
+17
| +0.2% | +$2.28K | 0.71% | 44 |
|
|
2018
Q4 | $1.11M | Buy |
8,642
+1,595
| +23% | +$222K | 0.62% | 38 |
|
|
2018
Q3 | $974K | Sell |
7,047
-280
| -4% | -$37.2K | 0.44% | 35 |
|
|
2018
Q2 | $889K | Sell |
7,327
-140
| -2% | -$17.5K | 0.41% | 41 |
|
|
2018
Q1 | $957K | Sell |
7,467
-726
| -9% | -$98.1K | 0.35% | 39 |
|
|
2017
Q4 | $1.15M | Sell |
8,193
-124
| -1% | -$17.3K | 0.47% | 28 |
|
|
2017
Q3 | $1.08M | Sell |
8,317
-80
| -1% | -$10.6K | 0.59% | 26 |
|
|
2017
Q2 | $1.11M | Sell |
8,397
-834
| -9% | -$106K | 0.51% | 41 |
|
|
2017
Q1 | $1.15M | Sell |
9,231
-2,515
| -21% | -$300K | 0.52% | 48 |
|
|
2016
Q4 | $1.35M | Sell |
11,746
-9,952
| -46% | -$1.15M | 0.69% | 40 |
|
|
2016
Q3 | $2.56M | Sell |
21,698
-25,944
| -54% | -$3.15M | 1.12% | 33 |
|
|
2016
Q2 | $5.78M | Buy |
47,642
+1,682
| +4% | +$191K | 2.21% | 4 |
|
|
2016
Q1 | $4.97M | Buy |
45,960
+3,962
| +9% | +$410K | 2.27% | 4 |
|
|
2015
Q4 | $4.31M | Buy |
41,998
+1,542
| +4% | +$155K | 2% | 5 |
|
|
2015
Q3 | $3.78M | Buy |
40,456
+15,179
| +60% | +$1.47M | 2.14% | 5 |
|
|
2015
Q2 | $2.46M | Buy |
25,277
+5,164
| +26% | +$517K | 1.54% | 11 |
|
|
2015
Q1 | $2.02M | Buy |
+20,113
| New | +$2.05M | 1.28% | 22 |
|
Other funds holding JNJ
Trust Company's JNJ Position: Q2 2026 in Review
Trust Company reduced its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, selling an estimated $378K and leaving 7,211 shares worth $1.83M. The position accounts for 0.17% of the portfolio, ranked #52.
Trust Company first reported a position in JNJ in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.78M in Q2 2016. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Trust Company held 7,211 shares of Johnson & Johnson worth $1.83M as of Q2 2026.
- Trust Company sold 1,623 Johnson & Johnson shares in Q2 2026, an estimated $378K.
- Johnson & Johnson made up 0.17% of Trust Company's portfolio in Q2 2026, its #52 holding.
- Trust Company first reported a position in Johnson & Johnson in Q1 2015 and has held it in 46 quarters since.
- Trust Company's Johnson & Johnson position peaked at $5.78M in Q2 2016.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.